Established in 2016, CDG Capital is an international investment management company which is excelling at exploring extraordinary portfolio companies through its expertise in Healthcare, High-End Manufacturing and TMT sectors with private equity investments.
Equipped with impressive investment performance and highly skilled professionals, CDG Capital is appointed as the sole advisor of China Reform Conson Soochow Overseas Fund I L.P. and CRF Envirotech Fund L.P. with AUM of US$650 million.
Relying on its abundant investment experience and industry resources, CDG Capital has invested in a number of outstanding companies, including Innovent Biologics (1801.HK), Akeso, Inc. (9926.HK), Tigermed (3347.HK), Farasis Energy (688567.SH) ,Antengene（6996.HK), RemeGen(9995.HK), etc.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 18 Harbour Road, Wan Chai, Suite 4704,central Plaza,hong Kong
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.cdginv.com
- Keywords
- Investment, Private Equity, Healthcare, TMT.
- HQ
- Hong Kong
晨岭资本 Cdg Capital Questions
晨岭资本 Cdg Capital's website is http://www.cdginv.com
晨岭资本 Cdg Capital's LinkedIn profile is https://hk.linkedin.com/company/cdgcapital
晨岭资本 Cdg Capital has
6 employees.
View email and phone details for 6
employees at 晨岭资本 Cdg Capital.
晨岭资本 Cdg Capital's industry is
Venture Capital and Private Equity Principals
晨岭资本 Cdg Capital's top competitors are
Qiming Venture Partners,
Basicfinder,
Dascapital 点石资本,
China Securities Co., Ltd.,
Fountainvest,
Primavera Capital Group,
大湾区共同家园投资有限公司 Greater Bay Area Homeland Investments Limited,
Basicai Inc,
Cdg Capital,
Baidu Venture.
晨岭资本 Cdg Capital's categories are Venture Capital and Private Equity Principals
晨岭资本 Cdg Capital's founding year is 2016
